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Abstract Isolation, purification, amino acid sequence determi- 
nation and X-ray crystal structure of buffalo ¢z-lactalbumin were 
performed in order to gain further knowledge of the molecular 
basis of ct-lactalbumin in the lactose synthase complex. The 
deduced amino acid sequence differs at one position from the 
bovine ~t-lactalbumin seouence (at position 17). The refined 
crystal structure at 2.3 A is very similar to those previously 
reported for human and baboon ~-lactalbumins. However, a 
portion of the molecule (residues 105-109) exhibits different 
conformation. It forms a 'flexible loop', and appears to be a 
functionally important region in forming the lactose synthase 
complex. 
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1. Introduction 
The biosynthesis of lactose in the lactating mammary  gland 
is controlled by the activity of the lactose synthase enzyme 
system (LS complex) [1]. This enzyme consists of two protein 
components:  l~-l,4-galactosyltransferase (GT), the catalytic 
component,  and c~-lactalbumin (c~-LA), the regulatory compo- 
nent. In tissues other than the lactating mammary  gland, GT  
catalyses the transfer of 13-galactose from UDP-galactose to 
the 4-position of [3-N-acetylglucosamine residues in the N- 
linked glycans of glycoproteins. In the presence of c~-LA, 
the Km of GT  for glucose is reduced by up to 3 orders of 
magnitude so that lactose synthesis proceeds effectively at 
physiological levels of glucose, cx-LA, a major protein of the 
whey fraction of milk, possesses a number  of biological fea- 
tures in addit ion to its role as a 'specifier' protein in the LS 
complex. Even though functionally divergent, it is homolo- 
gous to C-type lysozymes [2]. It is a calcium binding protein 
[3] and binds different metal ions [4,5]. The precise role of 
calcium ion in a -LA is not known, it appears that the role 
of calcium binding in vivo is to mediate the release and fold- 
ing of nascent LA at the site of translation [6] and is required 
for the stability of the protein. 
Two crystal structures of a -LA (baboon [7], human [8,9]) 
indicate that the conformation of c~-LA is very similar to that 
of C-type lysozyme. The Ca 2+ ion is positioned in a helix- 
turn-helix moti f  bridging two domains and forming one of 
the most rigid parts of the molecule. In an effort towards 
understanding the molecular mechanism of LA action in the 
LS complex, we have set about looking at sequence variation 
on LA's modulatory properties. Here we report the amino 
*Corresponding author or K.R. Acharya. 
acid.sequence and the 3D structure of buffalo milk c~-LA at 
2.3 A resolution determined using X-ray crystallography. 
2. Materials and methods 
2.1. Purification of buffalo milk ct-LA 
A pool of buffalo milk was defatted by centrifugation at 3000 rpm 
for 30 min at 10°C; the skimmed milk was then ultracentrifuged at 
16000 rpm for 16 h at 0°C to precipitate the casein fraction. The 
supernatant was treated with (NH4)2SO4 up to 50% saturation and 
the precipitate was resuspended in 0.06 M NaHCOa, at pH 8.3. The 
protein fraction obtained was chromatographed on a Sephadex G-75 
column (32x 1000 mm, Pharmacia, Uppsala, Sweden) using the same 
buffer as eluent. The fractions collected were tested by SDS-PAGE 
with a 250 Midget Electrophoresis Unit (LKB, Bromma, Sweden), 
following Laemmli [10], except that the stacking gel buffer was at 
pH 8.0 instead of pH 6.8. The resolving el was 12% T, 3% C and 
the stacking gel 4% T, 3% C and the gels were 0.75 mm thick. The 
fractions containing c~-LA were pooled and rechromatographed on an 
anion exchange Sephadex A-50 column (32×500 mm, Pharmacia, 
Uppsala, Sweden): eluent A was 20 mM Tris-HC1, pH 7.2 and eluent 
B was 20 mM Tris-HC1, 0.5 M NaC1, pH 7.2 with a linear gradient 
from 0 to 100% of B. To check the purity of c~-LA, the fractions were 
tested by SDS-PAGE followed by Western blotting using a Midget 
Multi Blot Electrophoresis Transfer Unit (LKB). The minigels were 
blotted onto Problott membrane (Applied Biosystems, Foster City, 
CA, USA), as described by Towbin [11], at 10°C and 120 mA with 
constant current for 60 min (methanol and SDS were omitted in the 
transfer buffer). The membrane was stained in 0.2% Coomassie bril- 
liant blue R250, dissolved in the destaining solution (5:1:4 methano- 
l:acetic acid :water). The bands showing an apparent molecular weight 
of about 14 kDa were cut out from the Problott membrane and 
directly microsequenced on an Applied Biosystems 470A gas-phase 
sequencer [12] equipped with a 120A phenylthiohydantoin-amino 
acid derivative analyser [13]. 
2.2. Amino acid analysis and sequence 
The amino acid composition of buffalo ot-LA and of its peptides 
was determined after hydrolysis with 6 N HCI at 110°C for 24 h under 
vacuum on a Beckman I18CL (Pal. Alto, CA, USA) amino acid 
analyser. For sequence analysis the protein was modified by reduction 
in 6 M guanidinium chloride, 0.001 M EDTA, 0.1 M Tris-HCl, pH 
8.3; 0.002 M dithiothreitol was added and the reduction proceeded 
under nitrogen, in the dark, at 37°C for 1 h. S-Carboxamidomethyla- 
tion was performed with 0.1 M iodoacetamide in the same conditions 
as for the reduction of the protein. The reduced, carboxamidomethyl- 
ated c~-LA was digested using different enzymes: 0.5 mg of protein 
were incubated with 3% (w/w) of endoprotease Glu-C (Boehringer, 
Mannheim, Germany) in 0.1 M NH4HCOa at 37°C for 6 h and the 
same amount with 1% trypsin (TPCK) (Worthington Biochemical 
Corp., Freehold, N J, USA) in 0.2 M N-ethylmorpholine acetate, pH 
8.3, at 37°C for 1 h; both reactions were stopped by freezing at 
-40°C. The peptides obtained were purified by RP-HPLC (Varian 
LC 5000, Pal, Alto, CA, USA) on a LiChrospher 100 RP-18 column 
(5 mm, Merck, Darmstadt, Germany) in 0.1% trifluoroacetic acid 
(TFA) and eluted with a linear gradient of 10 55% acetonitrile in 
0.1% TFA for 60 min at a flow rate of 0.7 ml/min. Some fractions 
were rechromatographed on the same column in 0.05 M ammonium 
acetate, pH 6,0 using a gradient of 0.0--75% acetonitrile at a flow rate 
of 0.7 ml/min. A limited proteolysis on the native protein was per- 
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Fig. 1. The complete amino acid sequence of buffalo milk ct-LA. The only position which differs from bovine ct-LA is position 17 (Asp (buffalo 
ct-LA), Gly (bovine cc-LA)). N = N-terminal sequence; T = trypsin; Vs = GIu-C; PL= limited proteolysis; black line corresponds to amino acid 
residues identified by sequencing; rey line corresponds to amino acid residues deduced from amino acid analysis. 
formed using 5% thermolysin (Sigma Chemical Co., St. Louis, MO, 
USA), in 0.05 M Tris-HC1, 0.005 M CaC12, pH 7.0 in 50% trifluoro- 
ethanol at 40°C for 45 min [14]. The complete amino acid sequence 
derived is shown in Fig. 1. 
2.3. Crystallisation 
Crystals of buffalo ct-LA were obtained at 16°C using the hanging 
drop vapour diffusion method from a reservoir solution containing 
0.2 M (NH4)2SO4, 0.1 M CH3COONa, 25% PEG 4000 and 10 mM 
CaCI2, pH 4.5. The protein was first dissolved in water and the hang- 
ing drops were placed on a siliconised glass cover slip with 3 pJ of the 
reservoir solution mixed with 3 gl of the protein solution to a final 
protein concentration of approximately 10 mg/ml; the volume of the 
reservoir was 800 gl. Triclinic crystals appeared within a few days: 
they belong to space group P1 (a=36.72 A, b= 39.55 ,&, c=42.88 A, 
c~ = 106.78 °, 13 = 90.98 °, "/= 104.72 °) with two molecules in the unit cell. 
2.4. Data collection, structure determination and refinement 
The X-ray data were collected (maximum resolution 2.3 A) on a 
Siemens area detector mounted on a Siemens rotatingoanode operat- 
ing at 45 kV and 70 mA. CuKt~ radiation 0~= 1.5418 A) was selected 
using a graphite monochromator. The data were processed using the 
XDS package of programs [15] to give a scaled set of intensities 
(Table 1). The structure was determined using the molecular eplace- 
ment technique with the program AMoRe [16] and the refined human 
ot-LA structure (1.7 A, resolution; [8]) as the starting model (75% 
sequence identity). After the initial rigid body refinement 
(R,,o,~t = 0.507), the buffalo ot-LA amino acid sequence was incorpo- 
rated into the model using the program O [17]. The resultant model 
was subjected to positional, simulated annealing and B-factor refine- 
ment using X-PLOR 3.1 [18] with the Engh and Huber force and 
geometric onstants [19]. Non-crystallographic restraints were used 
at the beginning but were released towards the end of the refinement. 
SIGMAA [20] weighted 2Fo-F¢ and Fo-Fc electron density maps were 
used for assessing the quality of the structure and for identifying the 
positions of water molecules respectively. Attempts were made to 
define the conformation of the tripeptide at the C-terminus (residues 
121 123) which were partially disordered in human and buffalo tx-LA. 
The final refined model (R,  ryst = 0.19 and Rfree = 0.29 between 8.0 and 
2.3 ,~ using all reflections) includes 1954 protein atoms, 2 Ca 2+ ions 
and 96 water molecules. The atomic coordinates of buffalo a-LA will 
be deposited in the Brookhaven Protein Data Bank. 
2.5. Electrospray mass spectrometric ( ESMS)  analysis. 
An aliquot (10 gl) of the HPLC purified ot-LA was directly sub- 
jected to ESMS analysis using a VG BIO-Q triple quadrupole mass 
spectrometer (VG Biotech) equipped with an electrospray ion source 
at a flow rate of 10 ml/min. The quadrupole was scanned from 400 to 
2000 m/z at 10 s/scan and the spectra were acquired using the MASS 
LINK software. Calibration was performed by a separate injection of 
lysozyme (Mr 14 306.6 Da). All mass values were reported as average 
masses, 
3. Results and discussion 
The amino acid sequence (Fig. 1) obtained by chemical 
methods clearly showed one difference at position 17 between 
buffalo (Asp) and bovine (Gly) ct-LAs. It has been confirmed 
by the X-ray structure of buffalo c~-LA (Fig. 2A). Further, the 
crystal structure of buffalo c~-LA showed another difference at 
position 27 (Ile) (Ile in human ct-LA) (Fig. 2B). However, the 
Edman degradation results showed a Val both from the N- 
terminal sequence of the native (Fig. 3A) and of the digested 
protein (Fig. 3B). This disagreement has been explained using 
mass spectrometry analysis. The ES spectrum showed a bell- 
shaped distribution of multiple charged ions in the region 
between m/z 1100 and 1800. Two major components could 
be distinguished in the spectra whose molecular weight was 
measured as 14236.4+0.9 Da and 14251 + 1.5 Da, respec- 
tively. On the basis of the accurate molecular mass value, 
the first component was identified as the buffalo et-LA con- 
taining four disulphide bridges (theoretical molecular weight 
14236 Da). The molecular weight of the second component 
was 14-15 Da higher than that of buffalo c~-LA. The relative 
abundance of the two proteins was estimated from the ionic 
current as 69% for the first component and 31% for the sec- 
ond. This confirms the existence of a mixture of two genetic 
variants in vivo; the one containing Ile at position 27 is pres- 
ent in a slightly lower percentage than the second variant 
containing Val and thus it would not be detectable with Ed- 
man degradation. However, it appears that in the crystals of 
buffalo c~-LA the lie variant is more predominant as observed 
in the electron density map. 
The overall features of the structure are similar to those 
reported for baboon and human a-LA [7--9] (Fig. 4). The 
root mean square (rms) deviation for the 120 equivalent C ~ 
atoms for human and buffalo c~-LA is 1.36 A (average devia- 
t ion 1.07 A). The most rigid part of the molecule is the Ca 2+ 
binding site which has similar conformation and ligand coor- 
dination as observed in other e~-LA structures. The only sig- 
nificant deviation in the peptide backbone occurs in the region 
between residues 105 and 109 adjacent o the bottom port ion 
of the cleft region (Fig. 4). In human and baboon ct-LA 
structures this port ion of the polypeptide adopts a distorted 
helical conformation whereas in buffalo t~-LA structure it 
Table 1 
Data processing and refinement statistics for buffalo milk ct-LA 
Cell dimensions: a=36.72, b=39.55, c=42.88 A, ot=106.78, 
13=90.98, ,/= 104.72 ° 
Resolution 20.0-2.3 
N,,, ~ 27 282 
Nu b 8940 
Overall completeness 88.2% 
I/o(I) (average) 19.3 
R~ym c 7.3% 
No. of reflections used in refinement 8743 
(8.0 2.3 A) 
R, ry~( 1, (F>0o)  19.1%; R~r~Y 29.7"/,, 
No. of protein atoms (two molecules) 1954 
No. of water molecules 96 
rms deviation in bond lengths (~,) 0.012 
bond angles (°) 1.66 
Average B-factors (~2) 
backbone 14.8 
all atoms 18.7 
water molecules 32.1 
calcium ion 14.5 
~Number of measurements, hNumber of unique reflections. 
CRsym = EhklEilli(hkl)-- < l(hkl) > I/ZhkIZili(hkl) where < I>  is the 
averaged intensity of the i observations of reflection hkl. 
d Rcryst = Z IIFoI-IFclI/Z'.Fol where Fo and Fc are the observed and cal- 
culated structure factor amplitudes, respectively, eRfree = Rcryst for a 
randomly selected 5% subset of reflections not used in the refinement 
[24]. 
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Fig. 2. Portions of the electron density map from buffalo c~-LA re- 
fined structure at (A) Asp*17 and (B) Ile-27. 
forms a 'flexible loop'. This local structural f exibility appears 
to be dependent on the crystallisation conditions as reported 
for human c(-LA [9] - at high pH (6.5-7.5) the helical con- 
formation is predominant (human and baboon c(-LA) whereas 
at low pH (4.6), as in the case of buffalo c~-LA, the loop 
structure is present. It has been observed before that at low 
pH, the hydrogen bond between the buried His-107 residue 
and the carboxylate group of Glu-25 (both are conserved in 
buffalo c~-LA) is disrupted, making the fully protonated His 
solvent accessible and hence the loop structure. 
The conformation of the flexible loop described here has 
particular interest in understanding c~-LA function since it 
comprises part of the GT interaction site. Since the amino 
acid sequence of buffalo milk c(-LA as described in this report 
is almost identical to the bovine sequence, we should be able 
to use the substantial mount of functional data available for 
the bovine protein. Based on mutagenesis data on bovine c~- 
LA, amino acid substitutions at position 106, 107 and 110 
have considerable effect on oc-LA's ability to bind GT [21]. 
Furthermore, the helix to loop transition appears to invoke 
subtle changes in the environment of His-32 (increased acces- 
sibility in buffalo c~-LA), an important residue implicated in 
Fig. 3. A: Chromatogram of PTH-aa identification after automatic 
Edman degradation of native c~-LA (residues 26 and 27). B: Chro- 
matogram of PTH-aa identification of part of the peptide from Vs 
protease digestion (residues 26, 27 and 28) at wavelength of 269 
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Fig. 4. A view of the C a backbone of human c~-LA (grey) and buf- 
falo c~-LA (black) is shown after least squares uperposition. A por- 
tion of the molecule which differs in the two structures (residues 
105-109), known to possess conformational flexibility (helix in hu- 
man ct-LA, [8]; coil in buffalo ot-LA, present study) is highlighted. 
The Ca 2+ ion is shown with large sphere. The figure was produced 
by MOLSCRIPT [25]. 
providing stabilising interactions for the bound monosacchar- 
ide when a-LA binds to GT. It is possible that conforma- 
tional flexibility of this region might allow structural adjust- 
ments upon complex formation. The enhanced con- 
formational flexibility of this particular egion has also been 
observed in recent crystallographic analysis of the crystal 
structures of guinea pig, goat and bovine c~-LA [22]. Interest- 
ingly, a structurally equivalent region of lysozyme has some 
flexibility (as judged from the crystallographic analyses of hen 
and human lysozymes [23]), but it does not undergo major 
rearrangements that are seen in ct-LA. However, detailed 
structural information is required on the ot-LA-GT complex 
to establish a definitive functional role for the 'flexible loop'. 
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